ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, April 05, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of

Related Keywords

San Diego , California , United States , South San Francisco , Dominic Piscitelli , Nasdaq , Exchange Commission , Compensation Committee Of The Board Directors , Securities Exchange , Linkedin , Pharmaceuticals Inc , Equity Incentive Plan , Grant Date , Equity Incentive , Nasdaq Rule , Securities Act , Securities Exchange Act , Chief Financial , Region ,